Treatment of human papillomavirus with peg-interferon alfa-2b and ribavirin

dc.creatorPavan, MHP
dc.creatorVelho, PENF
dc.creatorVigani, AG
dc.creatorGoncalves, FL
dc.creatorAoki, FH
dc.date2007
dc.dateJUN
dc.date2014-11-13T20:31:25Z
dc.date2015-11-26T17:11:25Z
dc.date2014-11-13T20:31:25Z
dc.date2015-11-26T17:11:25Z
dc.date.accessioned2018-03-28T23:59:55Z
dc.date.available2018-03-28T23:59:55Z
dc.identifierBrazilian Journal Of Infectious Diseases. Contexto, v. 11, n. 3, n. 383, n. 384, 2007.
dc.identifier1413-8670
dc.identifierWOS:000254388500017
dc.identifier10.1590/S1413-86702007000300017
dc.identifierhttp://www.repositorio.unicamp.br/jspui/handle/REPOSIP/77344
dc.identifierhttp://www.repositorio.unicamp.br/handle/REPOSIP/77344
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/77344
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1281092
dc.descriptionWe reported one case of human immunodeficiency virus and hepatitis C virus co-infected patient who presented a significant improvement of human papillomavirus (HPV) lesions during the treatment of chronic hepatitis using peg-interferon alfa-2b and ribavirin.
dc.description11
dc.description3
dc.description383
dc.description384
dc.languageen
dc.publisherContexto
dc.publisherSalvador
dc.publisherBrasil
dc.relationBrazilian Journal Of Infectious Diseases
dc.relationBraz. J. Infect. Dis.
dc.rightsfechado
dc.sourceWeb of Science
dc.subjecthepatitis C
dc.subjecthuman immunodeficiency virus
dc.subjecthuman papillomavirus
dc.subjectpegylated-interferon
dc.subjectribavirin
dc.titleTreatment of human papillomavirus with peg-interferon alfa-2b and ribavirin
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución